OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CAPR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Capricor Therapeutics (CAPR) Earnings Date & Reports

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CAPR is expected to report earnings to fall 10.38% to -47 cents per share on August 13

Capricor Therapeutics CAPR Stock Earnings Reports

Q2'25

Est.

$-0.47

Q1'25

Missed

by $0.21

Q4'24

Beat

by $0.01

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.01

The last earnings report on May 13 showed earnings per share of -52 cents, missing the estimate of -31 cents. With 142.60K shares outstanding, the current market capitalization sits at 414.57M.

View a ticker or compare two or three

Compare

CAPR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CAPR
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CAPR showed earnings on May 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Develops innovative products for the treatment of cardiovascular diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

10865 Road to the Cure

Phone

+1 858 727-1755

Employees

102

Web

https://www.capricor.com